Loading data for GRAL — first visit, this takes a few seconds.
GRAIL Inc. (GRAL)
NasdaqGS: GRAL
· Real-Time Price · USD
67.87
-0.37 (-0.54%)
At close: Aug 14, 2026, 8:00 PM
69.00
+1.66%
After-hours: 6:22 PM
GRAIL Inc. (GRAL) Stock Price, Analysis & Data
-0.54% (1D)
No data available
| Bid | 48.6 |
| Market Cap | 3.03B |
| Revenue (ttm) | 165.26M |
| Net Income (ttm) | -391.59M |
| Beta | 3.25 |
| EPS (ttm) | -9.69 |
| PE Ratio (ttm) | n/a |
| Forward PE | -6.88 |
| P/B (ttm) | 1.06 |
| P/S (ttm) | 18.34 |
| Earnings Date | Nov 11, 2026 |
| Ask | 86.89 |
| Volume | 414,080 |
| Avg. Volume (20D) | 708,024 |
| Open | 67.98 |
| Previous Close | 68.24 |
| Day's Range | 66.35 - 68.71 |
| 52-Week Range | 29.95 - 118.84 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About GRAL
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing cli...
Industry Diagnostics & Research
Sector Healthcare
IPO Date Jun 12, 2024
Employees 910
Stock Exchange NasdaqGS
Ticker Symbol GRAL
Website https://grail.com
Financial Performance
In 2025, GRAIL's revenue was 147.17M, an increase of 17.18% compared to the previous year's 125.59M. Earnings were -408.35M, a decrease of -79.85%.
Financial StatementsEarnings Surprise
GRAIL has released their quarterly earnings on Aug 5, 2026:
GRAIL Inc. is scheduled to release its earnings on Nov 11, 2026, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2